ARCUS BIOSCIENCES

Summary

Arcus Biosciences is a biotech company that visions to create new cancer therapeutics through the use of emerging insights in immunology.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 415 M

Avg. Deal Size£ 207 M

Market Context

Senior Management

Sort

Target: ARCUS BIOSCIENCES

Bidder: GILEAD SCIENCES

9 Service Providers

8 Dealmakers

£ 162 M

Value

Target: ARCUS BIOSCIENCES

Bidder: GILEAD SCIENCES

3 Service Providers

6 Dealmakers

£ 251 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy